Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

End-stage reflux nephropathy

R R Bailey

    Nephron
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Vesico-ureteric reflux causes chronic pyelonephritis and kidney scarring. This condition significantly contributes to end-stage renal failure, impacting patients needing dialysis or transplantation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Labetalol in the treatment of patients with hypertension and renal function impairment.

    British journal of clinical pharmacology·2015
    Same author

    Labetalol in the treatment of a patient with phaechromocytoma: a case report.

    British journal of clinical pharmacology·2015
    Same author

    The economic burden of Clostridium difficile.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
    Same author

    The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
    Same author

    Economic value of Acinetobacter baumannii screening in the intensive care unit.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
    Same author

    Economic value of norovirus outbreak control measures in healthcare settings.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2010
    Same journal

    Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

    Nephron·2026
    Same journal

    Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

    Nephron·2026
    Same journal

    Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

    Nephron·2026
    Same journal

    Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

    Nephron·2026
    Same journal

    Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

    Nephron·2026
    Same journal

    Long-Term Therapy with Eculizumab Biosimilar in Patients with Atypical Haemolytic Uraemic Syndrome: Outcomes of a Prospective Observational Study.

    Nephron·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Urology
    • Pediatric Nephrology

    Background:

    • Vesico-ureteric reflux (VUR) is a primary cause of reflux nephropathy, leading to small, scarred kidneys.
    • Reflux nephropathy is a significant factor in developing end-stage chronic renal failure.

    Purpose of the Study:

    • To determine the prevalence of end-stage reflux nephropathy in patients undergoing dialysis or transplantation.
    • To characterize the clinical presentation of patients with end-stage reflux nephropathy.

    Main Methods:

    • Retrospective analysis of 144 patients entering a dialysis-transplant program.
    • Review of patient records for renal function, hypertension, proteinuria, and history of urinary tract infections.

    Main Results:

    Related Experiment Videos

    • 18 (12.5%) of patients had end-stage reflux nephropathy.
    • Most patients presented with severe renal impairment, hypertension, and proteinuria.
    • Only one-third had a documented history of urinary tract infections.
    • Pregnancy-related complications were noted in 8 of 12 female patients.

    Conclusions:

    • Reflux nephropathy is a substantial contributor to end-stage renal failure.
    • Early diagnosis and management of VUR are crucial to prevent chronic kidney disease progression.